Global Neisseria meningitidis Infections Drug Market Analysis 2012-2017 and Forecast 2018-2023

Report ID: bc5642d1c14f Category: Pages: 80 99Strategy 1-Mar-18

$2,980$5,960

Clear

Summary
The global Neisseria meningitidis Infections Drug market will reach xxx Million USD in 2017 and CAGR xx% 2011-2017. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Neisseria meningitidis Infections Drug by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
MGBBP-3
NCL-195
TP-10
Others
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Beijing Minhai Biotechnology Co Ltd
Biological E Ltd
China National Pharmaceutical Group Corp
GlaxoSmithKline Plc
Griffith University
ImmunoBiology Ltd
JN-International Medical Corp
MGB Biopharma Ltd
Panacea Biotec Ltd
Pfizer Inc
Sanofi Pasteur SA
Serum Institute of India Ltd
Wellstat Vaccines LLC
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Recreational Vehicle
Commercial and Passenger Vehicle
Other 
Region Coverage (Regional Output, Demand & Forecast by Countries etc.):
North America
Europe
Asia-Pacific
South America
Middle East & Africa

Report ID: bc5642d1c14f Category: Pages: 80 99Strategy 1-Mar-18

Table of Content
1 Industry Overview
1.1 Neisseria meningitidis Infections Drug Industry
1.1.1 Overview
1.1.2 Development of Neisseria meningitidis Infections Drug
1.2 Market Segment
1.2.1 Upstream
1.2.2 Downstream
1.3 Cost Analysis
2 Industry Environment
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Neisseria meningitidis Infections Drug Market by Type
3.1 By Type
3.1.1 MGBBP-3
3.1.2 NCL-195
3.1.3 TP-10
3.1.4 Others
3.2 Market Size
3.3 Market Forecast
4 Major Companies List
4.1 Beijing Minhai Biotechnology Co Ltd (Company Profile, Sales Data etc.)
4.2 Biological E Ltd (Company Profile, Sales Data etc.)
4.3 China National Pharmaceutical Group Corp (Company Profile, Sales Data etc.)
4.4 GlaxoSmithKline Plc (Company Profile, Sales Data etc.)
4.5 Griffith University (Company Profile, Sales Data etc.)
4.6 ImmunoBiology Ltd (Company Profile, Sales Data etc.)
4.7 JN-International Medical Corp (Company Profile, Sales Data etc.)
4.8 MGB Biopharma Ltd (Company Profile, Sales Data etc.)
4.9 Panacea Biotec Ltd (Company Profile, Sales Data etc.)
4.10 Pfizer Inc (Company Profile, Sales Data etc.)
4.11 Sanofi Pasteur SA (Company Profile, Sales Data etc.)
4.12 Serum Institute of India Ltd (Company Profile, Sales Data etc.)
4.13 Wellstat Vaccines LLC (Company Profile, Sales Data etc.)
5 Market Competition
5.1 Company Competition
5.2 Regional Market by Company
6 Market Demand
6.1 Demand Situation
6.1.1 Demand in Recreational Vehicle
6.1.2 Demand in Commercial and Passenger Vehicle
6.1.3 Demand in Other 
6.2 Regional Demand Comparison
6.3 Demand Forecast
7 Region Operation
7.1 Regional Output
7.2 Regional Market
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
7.3.1.2 by Country (U.S., Canada, Mexico)
7.3.2 Europe
7.3.2.1 Overview
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
7.3.3 Asia-Pacific
7.3.3.1 Overview
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
7.3.4 South America
7.3.4.1 Overview
7.3.4.2 by Country (Brazil, Argentina etc.)
7.3.5 Middle East & Africa
7.3.5.1 Overview
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
7.4 Regional Forecast
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
8.1.3 Manufacturers Gross Margin Analysis
8.2 Value Chain
8.3 Marketing Channel
9 Research Conclusion

Figure Neisseria meningitidis Infections Drug Industry Chain Structure
Figure Global Neisseria meningitidis Infections Drug Market Growth 2012-2017, by Type, in USD Million
Figure Global Neisseria meningitidis Infections Drug Market Growth 2012-2017, by Type, in Volume
Figure North America Neisseria meningitidis Infections Drug Market, by Company, in 2017
Figure Europe Neisseria meningitidis Infections Drug Market Market, by Company, in 2017
Figure Asia-Pacific Neisseria meningitidis Infections Drug Market Market, by Company, in 2017
Figure South America Neisseria meningitidis Infections Drug Market Market, by Company, in 2017
Figure Middle East & Africa Neisseria meningitidis Infections Drug Market Market, by Company, in 2017
Figure North America Neisseria meningitidis Infections Drug Market Size and Growth 2012-2017, in USD Million
Figure North America Neisseria meningitidis Infections Drug Market Size and Growth 2012-2017, in Volume
Figure Europe Neisseria meningitidis Infections Drug Market Size and Growth 2012-2017, in USD Million
Figure Europe Neisseria meningitidis Infections Drug Market Size and Growth 2012-2017, in Volume
Figure Asia-Pacific Neisseria meningitidis Infections Drug Market Size and Growth 2012-2017, in USD Million
Figure Asia-Pacific Neisseria meningitidis Infections Drug Market Size and Growth 2012-2017, in Volume
Figure South America Neisseria meningitidis Infections Drug Market Size and Growth 2012-2017, in USD Million
Figure South America Neisseria meningitidis Infections Drug Market Size and Growth 2012-2017, in Volume
Figure Middle East & Africa Neisseria meningitidis Infections Drug Market Size and Growth 2012-2017, in USD Million
Figure Middle East & Africa Neisseria meningitidis Infections Drug Market Size and Growth 2012-2017, in Volume
Figure Marketing Channels Overview